Brachytherapy: is it really “better” as a first-line treatment for low- and intermediate-risk prostate cancer?

Posted on February 2, 2012 by Sitemaster

An analysis of data on treatment of nearly 137,500 men treated for prostate cancer between 1991 and 2007 has suggested that permanent seed brachytherapy may be safer, less costly, and at least as effective as any other widely available form of first-line therapy for men with low- and intermediate-risk prostate cancer.

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , , , | 3 Comments »

Increasing focus on the appropriate definition (and management) of prostate “cancer”

Posted on January 14, 2012 by Sitemaster

As many readers will be aware, there has been a recent and increasing focus on whether abnormal pathological findings on biopsy classified as Gleason grade 3 + 3 = 6 should really be classified as “cancer” at all. This also has major implications for its management.

Filed under: Diagnosis, Management, Risk | Tagged: , , , , | 14 Comments »

“How to select the optimal therapy for early-stage prostate cancer”

Posted on January 11, 2012 by Sitemaster

The title of this commentary is also the title of a review article just published in Critical Reviews in Oncology/Hematology. While this is hardly a “first tier” journal for the average urologist or radiation oncologist, it is still gratifying to see an increase in this type of article in the peer-reviewed literature.

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , | 2 Comments »

Sex after RP — it’s out there on the radio

Posted on October 5, 2011 by Sitemaster

Many readers of The “New” Prostate Cancer InfoLink may be interested in listening to or reading the transcript of a program on Science Friday on National Public Radio that aired last Monday.

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , | 1 Comment »

Beyond the Abstract — Treatment options for localized prostate cancer

Posted on September 19, 2011 by Sitemaster

The following article, by Ravinder Mohan, MD, PhD, is reproduced from the UroToday web site with kind permission of Dr. Mohan and the publishers of UroToday. We had previously commented on the original article, published last month in American Family Physician.

Filed under: Diagnosis, Management, Risk, Treatment | Tagged: , , , , , | 5 Comments »

GE heads up $1 billion cancer detection and treatment plan

Posted on September 15, 2011 by Sitemaster

If you have a really innovative idea that might impact the diagnosis and treatment of prostate cancer, now’s the time to get your proposal in to GE and its venture capital partners.

Filed under: Diagnosis, Management, Treatment | Tagged: , , , | 2 Comments »

What DID the doctor actually tell you about your prostate cancer?

Posted on September 6, 2011 by Sitemaster

It is well understood that there can be big differences between what we are told and what we later say and think that we heard. It is also the case that what we are told may commonly reflect the beliefs of the person doing the telling (as opposed to actual, factual information).

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , , | 7 Comments »

Whole ginger extract in prostate cancer prevention and treatment

Posted on August 25, 2011 by Sitemaster

The full text of a new article on the potential of whole ginger extract (WGE) in the prevention and treatment of of prostate cancer has recently been published in the British Journal of Nutrition.

Filed under: Drugs in development, Living with Prostate Cancer, Management, Prevention, Treatment, Uncategorized | Tagged: , , , , | 3 Comments »

Utilization of standard treatments for localized prostate cancer by Medicare beneficiaries

Posted on July 27, 2011 by Sitemaster

In a new paper just published on-line in the Journal of Urology, Kapoor et al. have provided data on trends in the utilization of various major types of treatment for the management of localized prostate cancer among Medicare beneficiaries in the USA between 2006 and 2008.

Filed under: Management, Treatment | Tagged: , , , , , , | Leave a Comment »

Can ultrasensitive PSA at 3 years post-surgery project delayed BCR?

Posted on June 29, 2011 by Sitemaster

A research team at New York University School of Medicine has reported data suggesting that a single ultrasensitive PSA test result may be able to project risk for delayed biochemical recurrence (BCR) of prostate cancer at 3 years after a radical prostatectomy.

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , | 3 Comments »

The role of exercise in prostate cancer management

Posted on June 27, 2011 by Sitemaster

Prostate cancer patients in general, but most especially men receiving androgen deprivation therapy (ADT), experience symptoms  and side effects of treatment that make it difficult to maintain their independence and quality of life. A recent review states that exercise may offset many of the side effects of ADT as well as those of the cancer [...]

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , | 2 Comments »

Psychiatric treatment among Swedish men with prostate cancer

Posted on June 14, 2011 by Sitemaster

A new paper in the European Journal of Cancer suggests that men with prostate cancer are at increased risk for depression, for post-traumatic stress disorder, and for use of antidepressant drugs compared to age-matched controls.

Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: , , , , , | 3 Comments »

Diagnosis and management of localized prostate cancer: the Cleveland Clinic approach

Posted on May 29, 2011 by Sitemaster

A recent article in the Cleveland Clinic Journal of Medicine provides a summary of the way three leading specialists at this institution approach the diagnosis and management of localized prostate cancer today.

Filed under: Diagnosis, Management, Risk, Treatment | Tagged: , , | Leave a Comment »

Genetics, genomics, and improvements in the management of prostate cancer

Posted on April 29, 2011 by Sitemaster

Over the past few years we have seen a great deal of discussion of this or that new gene or single nucleotide polymorphism (SNP) or other set of genomic data and the potential of such information to improve the diagnosis or the prognosis of prostate cancer.

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: , , , , , | Leave a Comment »

So what IS the point of “screening” for prostate cancer?

Posted on April 15, 2011 by Sitemaster

A media release issued yesterday by Dr. David Samadi, a specialist in minimally invasive surgery at Mount Sinai Medical Center in New York City, has questioned whether the purpose of prostate cancer screening is to save lives or to prevent progressive prostate cancer.

Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: , , , , , | 6 Comments »

Next Page »
Follow

Get every new post delivered to your Inbox.

Join 269 other followers